CASCELLA ROBERT

Director Robert Cascella buys 100,000 shares of Neuronetics (STIM) at $0.75; stock now at $0.73, down 84.8% from 52-week high

Robert Cascella, a director, purchased 100,000 shares at $0.75 on 2024-09-12, increasing his holdings by 28.3% to 453,098 shares. The transaction occurs as STIM trades near its 52-week low of $0.73, down 84.8% from its 52-week high of $4.81. Cascella's cross-ticker track record shows 6 prior open-market buys with an average 90-day return of -35.8% and a 0.00% win rate at the 90-day mark, while his 5 prior buys at STIM have similarly underperformed—most notably a 2024-06-06 purchase that returned -59.9% over 90 days. The company remains unprofitable with a net loss of $9,832,000.00 in the latest quarter against revenue of $16,450,000.00 and a market cap of $22,115,689.45. This purchase pattern—repeated accumulation during sustained price decline—warrants examination of the motivations and risks underlying the director's continued investment in a distressed asset.

Director Cascella buys 39,000 shares of STIM at $1.07 avg; stock down 79.0% from 52-week high, company unprofitable.

Director Robert Cascella purchased 39,000 shares in two tranches (35,000 shares at $1.06 on 2024-08-16 and 4,000 shares at $1.14 on 2024-08-19) for a blended average price of $1.07, increasing his holdings by 12.4% to 353,098 shares. The purchases occurred during severe price deterioration: the stock is trading at $1.01, down 79.0% from its 52-week high of $4.81 and down 47.5% over the prior 30 days. Neuronetics reported net income of $-9,832,000.00 in its latest quarter and was unprofitable over its full fiscal year, with a market cap of $30,598,419.65. Cascella's cross-ticker track record shows 0 of 4 prior buys were well-timed at the 90-day mark (average 90d return -11.8%), and his three prior trades at STIM show a 30-day return of -10.3% on the June 2024 purchase, though the more recent August purchases are not yet measurable. This buy activity in a deeply depressed stock issued by an unprofitable company warrants investor scrutiny into the insider's conviction and information.

Director Cascella buys 70,000 shares at blended avg $0.84 amid 76.7% decline from 52-week high

Director Robert Cascella executed 2 separate open-market purchases totaling 70,000 shares for $58,450.00 ($0.84 blended average) on 2024-08-14 and 2024-08-15, increasing his holdings by 28.7%. The timing occurs as the stock is -76.7% from its 52-week high and down -44.0% over 30 days. Cascella's prior trades at STIM (2 prior buys, most recent 2024-06-06 showing -10.3% 30-day return) have not demonstrated well-timed entry points, with his cross-ticker track record showing 0 of 3 prior buys with positive 90-day returns. The company posted negative net income of $-9,832,000.00 over its latest full fiscal year and remains unprofitable, trading at a market cap of $33,930,920.80 against recent quarterly revenue of $16,450,000.00.